{"name":"Essex Woodlands Health Ventures","permalink":"essex-woodlands-health-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/essex-woodlands-health-ventures","homepage_url":"http://www.ewhv.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"650-543-1555","description":"","email_address":"paloalto@ewhv.com","number_of_employees":null,"founded_year":1985,"founded_month":null,"founded_day":null,"tag_list":"","alias_list":"","created_at":"Fri Apr 17 12:25:48 UTC 2009","updated_at":"Fri Apr 29 06:44:44 UTC 2011","overview":"<p>Essex Woodlands was founded in 1985 with the establishment of Essex Venture Fund I, LP. Since 1985, the Partnership has raised seven additional funds with nearly $2.5 billion under management, making Essex Woodlands one of the worldâ€™s largest and most established healthcare venture capital firms. The team is comprised of 23 professionals with principal offices in Palo Alto, Houston, New York and London. This team brings over 300 years of collective healthcare experience.</p>\n\n<p>For over 20 years, the firm has maintained its dedicated focus to diversified healthcare investingâ€”primarily serving as lead investor in the founding or the critical financings of over 100 healthcare companies in pharmaceutical, biotechnology, medical device, services and information technology sectors. In addition to its long-standing commitment to early stage companies, the firm has over a decade of experience as a leading late-stage healthcare investor, which includes mature venture, growth equity and PIPE investment opportunities.</p>","image":{"available_sizes":[[[150,22],"assets/images/resized/0005/2525/52525v2-max-150x150.jpg"],[[250,37],"assets/images/resized/0005/2525/52525v2-max-250x250.jpg"],[[306,46],"assets/images/resized/0005/2525/52525v2-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"335 Bryant Street","address2":"3rd Floor","zip_code":"94301","city":"Palo Alto","state_code":"CA","country_code":"USA","latitude":37.44719,"longitude":-122.163247}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.symphogen.com/web/guest/newsarchive/readmore?p_p_id=56_INSTANCE_ZUuU&articleId=90","source_description":"Symphogen secures â‚¬ 33 million financing to support clinical development of antibody products","raised_amount":33000000,"raised_currency_code":"EUR","funded_year":2009,"funded_month":2,"funded_day":2,"company":{"name":"Symphogen","permalink":"symphogen","image":{"available_sizes":[[[150,61],"assets/images/resized/0004/1671/41671v1-max-150x150.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-250x250.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/xanodyne-pharmaceuticals-inc-series-d-38m/","source_description":"Xanodyne Pharmaceuticals, Inc.: Series D $38M","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":23,"company":{"name":"Xanodyne","permalink":"xanodyne","image":{"available_sizes":[[[150,49],"assets/images/resized/0005/0368/50368v1-max-150x150.png"],[[250,83],"assets/images/resized/0005/0368/50368v1-max-250x250.png"],[[286,95],"assets/images/resized/0005/0368/50368v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/press-releases/catalyst-biosciences-raises-40-million-series-c-financing?utm_medium=nl&utm_source=internal&cmp-id=EMC-NL-FB&dest=FB","source_description":"Catalyst Biosciences Raises $40 Million in Series C Financing","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":12,"funded_day":3,"company":{"name":"Catalyst Biosciences","permalink":"catalyst-biosciences","image":{"available_sizes":[[[150,95],"assets/images/resized/0005/0378/50378v1-max-150x150.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-250x250.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Capital Report Index","raised_amount":24500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":23,"company":{"name":"Chroma Therapeutics","permalink":"chroma-therapeutics","image":{"available_sizes":[[[150,52],"assets/images/resized/0005/2160/52160v1-max-150x150.jpg"],[[250,87],"assets/images/resized/0005/2160/52160v1-max-250x250.jpg"],[[257,90],"assets/images/resized/0005/2160/52160v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2008/03/15/nellix-raises-65m-for-aneurysm-grafts/","source_description":"Nellix raises $6.5M for aneurysm grafts","raised_amount":6500000,"raised_currency_code":"USD","funded_year":2008,"funded_month":3,"funded_day":15,"company":{"name":"Nellix","permalink":"nellix","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/2523/52523v1-max-150x150.jpg"],[[174,64],"assets/images/resized/0005/2523/52523v1-max-250x250.jpg"],[[174,64],"assets/images/resized/0005/2523/52523v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/02-21-2008/0004759801&EDATE=","source_description":"Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial","raised_amount":28800000,"raised_currency_code":"USD","funded_year":2008,"funded_month":2,"funded_day":21,"company":{"name":"Accumetrics","permalink":"accumetrics","image":{"available_sizes":[[[150,66],"assets/images/resized/0005/2704/52704v1-max-150x150.jpg"],[[250,110],"assets/images/resized/0005/2704/52704v1-max-250x250.jpg"],[[253,112],"assets/images/resized/0005/2704/52704v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2008/01/11/secretive-oraya-raises-more-funds-for-eye-devices/","source_description":"Secretive Oraya raises more funds for eye devices","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":11,"company":{"name":"Oraya Therapeutics","permalink":"oraya-therapeutics","image":{"available_sizes":[[[150,97],"assets/images/resized/0005/2832/52832v1-max-150x150.jpg"],[[172,112],"assets/images/resized/0005/2832/52832v1-max-250x250.jpg"],[[172,112],"assets/images/resized/0005/2832/52832v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/oraya-garners-42m-third-venture-round/2009-07-20?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Oraya garners $42M in third venture round","raised_amount":42000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":20,"company":{"name":"Oraya Therapeutics","permalink":"oraya-therapeutics","image":{"available_sizes":[[[150,97],"assets/images/resized/0005/2832/52832v1-max-150x150.jpg"],[[172,112],"assets/images/resized/0005/2832/52832v1-max-250x250.jpg"],[[172,112],"assets/images/resized/0005/2832/52832v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.fiercebiotech.com/story/complete-genomics-bags-45m-round-sequencing/2009-08-24?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Complete Genomics bags $45M round for sequencing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":24,"company":{"name":"Complete Genomics","permalink":"complete-genomics","image":{"available_sizes":[[[150,43],"assets/images/resized/0005/7515/57515v2-max-150x150.png"],[[250,72],"assets/images/resized/0005/7515/57515v2-max-250x250.png"],[[289,84],"assets/images/resized/0005/7515/57515v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://venturebeat.com/2007/06/18/stealthy-oraya-raises-4m-for-medical-devices/","source_description":"Stealthy Oraya raises $4M for medical devices","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":18,"company":{"name":"Oraya Therapeutics","permalink":"oraya-therapeutics","image":{"available_sizes":[[[150,97],"assets/images/resized/0005/2832/52832v1-max-150x150.jpg"],[[172,112],"assets/images/resized/0005/2832/52832v1-max-250x250.jpg"],[[172,112],"assets/images/resized/0005/2832/52832v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2007/05/11/stratagent-closes-16m-round-for-needle-free-injections/","source_description":"StrataGent closes $16M round for needle-free injections","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":11,"company":{"name":"StrataGent Life Sciences","permalink":"stratagent-life-sciences","image":null}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2006/12/08/neovista-a-co-targeting-age-related-macular-degeneration-raises-41m/","source_description":"NeoVista, a co. targeting age-related macular degeneration, raises $41M","raised_amount":41000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":12,"funded_day":8,"company":{"name":"NeoVista","permalink":"neovista","image":{"available_sizes":[[[150,102],"assets/images/resized/0005/9227/59227v1-max-150x150.jpg"],[[219,150],"assets/images/resized/0005/9227/59227v1-max-250x250.jpg"],[[219,150],"assets/images/resized/0005/9227/59227v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://news.morningstar.com/newsnet/ViewNews.aspx?article=/BW/20091117005641_univ.xml","source_description":"MorningStar","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":17,"company":{"name":"Entellus Medical","permalink":"entellus-medical","image":{"available_sizes":[[[150,41],"assets/images/resized/0006/6593/66593v1-max-150x150.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-250x250.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020091216e5cg00001&r=Rss&s=DJFVLS","source_description":"Swiss Protein Therapy Co. Molecular Partners Pulls In $44M Series B  ","raised_amount":44200000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":16,"company":{"name":"Molecular Partners","permalink":"molecular-partners","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/0288/70288v1-max-150x150.jpg"],[[185,61],"assets/images/resized/0007/0288/70288v1-max-250x250.jpg"],[[185,61],"assets/images/resized/0007/0288/70288v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2010/01/revance-raises-25m-in-series-d.html","source_description":"Revance Raises $25M in Series D Financing","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":4,"company":{"name":"Revance Therapeutics","permalink":"revance-therapeutics","image":{"available_sizes":[[[98,36],"assets/images/resized/0007/1055/71055v1-max-150x150.png"],[[98,36],"assets/images/resized/0007/1055/71055v1-max-250x250.png"],[[98,36],"assets/images/resized/0007/1055/71055v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020100116e61j0002t&r=Rss&s=DJFVW","source_description":"Essex Woodlands, Providence Equity Invest $120M In IkaSystems  ","raised_amount":120000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":19,"company":{"name":" ikaSystems","permalink":"ikasystems","image":{"available_sizes":[[[150,33],"assets/images/resized/0007/4238/74238v1-max-150x150.jpg"],[[218,49],"assets/images/resized/0007/4238/74238v1-max-250x250.jpg"],[[218,49],"assets/images/resized/0007/4238/74238v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/accumetrics-inc-series-e-166m/","source_description":"Accumetrics, Inc.: Series E $16.6M","raised_amount":16600000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":21,"company":{"name":"Accumetrics","permalink":"accumetrics","image":{"available_sizes":[[[150,66],"assets/images/resized/0005/2704/52704v1-max-150x150.jpg"],[[250,110],"assets/images/resized/0005/2704/52704v1-max-250x250.jpg"],[[253,112],"assets/images/resized/0005/2704/52704v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://sec.gov/Archives/edgar/vprr/04/9999999997-04-029551","source_description":"SEC D/A","raised_amount":13500000,"raised_currency_code":"USD","funded_year":2004,"funded_month":7,"funded_day":1,"company":{"name":"Accumetrics","permalink":"accumetrics","image":{"available_sizes":[[[150,66],"assets/images/resized/0005/2704/52704v1-max-150x150.jpg"],[[250,110],"assets/images/resized/0005/2704/52704v1-max-250x250.jpg"],[[253,112],"assets/images/resized/0005/2704/52704v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://ceptiontx.com/news/news001.htm","source_description":"Ception Therapeutics Raises $63 Million in Series C Financing","raised_amount":63000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":1,"funded_day":29,"company":{"name":"Ception Therapeutics","permalink":"ception-therapeutics","image":{"available_sizes":[[[149,150],"assets/images/resized/0007/7999/77999v1-max-150x150.png"],[[191,192],"assets/images/resized/0007/7999/77999v1-max-250x250.png"],[[191,192],"assets/images/resized/0007/7999/77999v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.coriumgroup.com/downloads/seriescpressrelease.pdf","source_description":"Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":9,"funded_day":26,"company":{"name":"Corium International","permalink":"corium-international","image":{"available_sizes":[[[150,44],"assets/images/resized/0008/0079/80079v1-max-150x150.jpg"],[[195,58],"assets/images/resized/0008/0079/80079v1-max-250x250.jpg"],[[195,58],"assets/images/resized/0008/0079/80079v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.chromatherapeutics.com/press-releases/Press-Release-7.pdf","source_description":"CHROMA THERAPEUTICS COMPLETES $53 MILLION SERIES C FINANCING","raised_amount":53000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":4,"funded_day":3,"company":{"name":"Chroma Therapeutics","permalink":"chroma-therapeutics","image":{"available_sizes":[[[150,52],"assets/images/resized/0005/2160/52160v1-max-150x150.jpg"],[[250,87],"assets/images/resized/0005/2160/52160v1-max-250x250.jpg"],[[257,90],"assets/images/resized/0005/2160/52160v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://bulletin.sciencebusiness.net/sb/login.php?page=/ebulletins/showissue.php3?page=/548/art/4700","source_description":"Symphogen gets $25M for clinical trials for bleeding treatment","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":1,"funded_day":10,"company":{"name":"Symphogen","permalink":"symphogen","image":{"available_sizes":[[[150,61],"assets/images/resized/0004/1671/41671v1-max-150x150.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-250x250.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/tearscience-inc-series-c-445m/","source_description":"TearScience, Inc.: Series C $44.5M","raised_amount":44500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":6,"company":{"name":"TearScience","permalink":"tearscience","image":{"available_sizes":[[[150,9],"assets/images/resized/0008/6329/86329v1-max-150x150.png"],[[250,16],"assets/images/resized/0008/6329/86329v1-max-250x250.png"],[[450,29],"assets/images/resized/0008/6329/86329v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.lsoncology.com/press_releases/release/pr_1206666394","source_description":"LIGHT SCIENCES ONCOLOGY COMPLETES SECOND CLOSING IN $67 MILLION FINANCING FOR LATE STAGE DEVELOPMENT OF LITXâ„¢ AND ANNOUNCES ADDITIONAL DIRECTORS","raised_amount":67000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":12,"funded_day":14,"company":{"name":"Light Sciences Oncology","permalink":"light-sciences-oncology","image":{"available_sizes":[[[150,39],"assets/images/resized/0006/5310/65310v1-max-150x150.png"],[[244,65],"assets/images/resized/0006/5310/65310v1-max-250x250.png"],[[244,65],"assets/images/resized/0006/5310/65310v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.completegenomics.com/news-events/press-releases/Complete-Genomics-Inc-Announces-Completion-of-39-Million--Series-E-Financing-and-Addresses-Illumina-Patent-Infringement-Lawsuit-101026744.html","source_description":"Complete Genomics, Inc. Announces Completion of $39 Million Series E Financing ","raised_amount":39000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":19,"company":{"name":"Complete Genomics","permalink":"complete-genomics","image":{"available_sizes":[[[150,43],"assets/images/resized/0005/7515/57515v2-max-150x150.png"],[[250,72],"assets/images/resized/0005/7515/57515v2-max-250x250.png"],[[289,84],"assets/images/resized/0005/7515/57515v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2010/09/accumetrics-raises-additional-7m.html","source_description":"Accumetrics Raises Additional $7M","raised_amount":7000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":1,"company":{"name":"Accumetrics","permalink":"accumetrics","image":{"available_sizes":[[[150,66],"assets/images/resized/0005/2704/52704v1-max-150x150.jpg"],[[250,110],"assets/images/resized/0005/2704/52704v1-max-250x250.jpg"],[[253,112],"assets/images/resized/0005/2704/52704v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://www.xconomy.com/san-francisco/2010/10/14/cell-biosciences-nabs-20m-buys-convergent/","source_description":"Cell Biosciences Nabs $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":14,"company":{"name":"ProteinSimple","permalink":"cell-biosciences","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/0799/40799v3-max-150x150.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-250x250.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://investor.endologix.com/releasedetail.cfm?ReleaseID=523807","source_description":"Endologix to Acquire Nellix","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":27,"company":{"name":"Endologix","permalink":"endologix","image":{"available_sizes":[[[150,54],"assets/images/resized/0010/7812/107812v1-max-150x150.png"],[[165,60],"assets/images/resized/0010/7812/107812v1-max-250x250.png"],[[165,60],"assets/images/resized/0010/7812/107812v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/01/symphogen-closes-100m-round-of.html","source_description":"Symphogen Closes â‚¬100M Round of Financing","raised_amount":100000000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":1,"funded_day":6,"company":{"name":"Symphogen","permalink":"symphogen","image":{"available_sizes":[[[150,61],"assets/images/resized/0004/1671/41671v1-max-150x150.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-250x250.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://onbiovc.com/symphogen-as-series-f-1354m/","source_description":"Symphogen, AS: Series F $135.4M","raised_amount":135400000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":14,"company":{"name":"Symphogen","permalink":"symphogen","image":{"available_sizes":[[[150,61],"assets/images/resized/0004/1671/41671v1-max-150x150.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-250x250.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/06/revance-therapeutics-closes-45m-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Revance Therapeutics Closes $45M Financing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":10,"company":{"name":"Revance Therapeutics","permalink":"revance-therapeutics","image":{"available_sizes":[[[98,36],"assets/images/resized/0007/1055/71055v1-max-150x150.png"],[[98,36],"assets/images/resized/0007/1055/71055v1-max-250x250.png"],[[98,36],"assets/images/resized/0007/1055/71055v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.finsmes.com/2011/08/entellus-medical-completes-35m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Entellus Medical Completes $35M Funding Round","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":17,"company":{"name":"Entellus Medical","permalink":"entellus-medical","image":{"available_sizes":[[[150,41],"assets/images/resized/0006/6593/66593v1-max-150x150.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-250x250.png"],[[151,42],"assets/images/resized/0006/6593/66593v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/09/breatheamerica-closes-22m-series-equity-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"BreatheAmerica Closes $22M Series B Equity Financing","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":6,"company":{"name":"BreatheAmerica","permalink":"breathe-america","image":{"available_sizes":[[[150,24],"assets/images/resized/0012/3024/123024v1-max-150x150.png"],[[250,40],"assets/images/resized/0012/3024/123024v1-max-250x250.png"],[[343,55],"assets/images/resized/0012/3024/123024v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/05/kona-medical-raises-30m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Kona Medical Raises $30M in Series C Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":30,"company":{"name":"Kona Medical","permalink":"kona-medical","image":{"available_sizes":[[[150,41],"assets/images/resized/0019/3225/193225v1-max-150x150.jpg"],[[208,58],"assets/images/resized/0019/3225/193225v1-max-250x250.jpg"],[[208,58],"assets/images/resized/0019/3225/193225v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.bizjournals.com/sanfrancisco/news/2012/12/04/kona-medical-raises-10m-in-series-c.html","source_description":"Kona Medical raises $10 million in new Series C funding","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":12,"funded_day":4,"company":{"name":"Kona Medical","permalink":"kona-medical","image":{"available_sizes":[[[150,41],"assets/images/resized/0019/3225/193225v1-max-150x150.jpg"],[[208,58],"assets/images/resized/0019/3225/193225v1-max-250x250.jpg"],[[208,58],"assets/images/resized/0019/3225/193225v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}